Connection

Nadim Mahmud to Transplantation, Autologous

Back to Details
This is a "connection" page, showing publications Nadim Mahmud has written about Transplantation, Autologous.
Nadim Mahmud
Connection Strength
0.039
Transplantation, Autologous
  1. A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma. Leuk Lymphoma. 2018 07; 59(7):1666-1671.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.